Sanara MedTech (SMTI) Return on Equity (2011 - 2026)

Sanara MedTech has reported Return on Equity for 13 years, with the latest figure at 0.05% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity fell 5.0% year-over-year to 0.05%; the trailing twelve-month figure through Mar 2026 stood at 0.05% (down 5.0% YoY), and the FY2025 full-year result was 0.02%, down 1.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.05%, up from 0.06% in the prior quarter.
• The five-year high for Return on Equity was 0.0% in Q4 2023, with the low at 0.06% in Q4 2025.
• Historically, Return on Equity has averaged 0.01% across 5 years, with a median of 0.0% in 2023.
• Annual changes were most pronounced in 2022 — Return on Equity changed 0 bps — and 2025, when it declined 6 bps.
• Sanara MedTech's Return on Equity stood at 0.0% in 2022, then jumped by 44 bps to 0.0% in 2023, then sank by 172 bps to 0.0% in 2024, then sank by 2119 bps to 0.06% in 2025, then climbed by 14 bps to 0.05% in 2026.
• The last three Return on Equity figures came in at 0.05% (Q1 2026), 0.06% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.